Impact of Contextual Factors and Substance Characteristics on Perspectives toward Cognitive Enhancement
Sattler S, Forlini C, Racine É, Sauer C (2013)
PLoS ONE 8(8): e71452.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Autor*in
Einrichtung
Abstract / Bemerkung
Enhancing cognitive performance with substances–especially prescription drugs–is a fiercely debated topic among scholars and in the media. The empirical basis for these discussions is limited, given that the actual nature of factors that influence the acceptability of and willingness to use cognitive enhancement substances remains unclear. In an online factorial survey, contextual and substance-specific characteristics of substances that improve academic performance were varied experimentally and presented to respondents. Students in four German universities rated their willingness to use and moral acceptance of different substances for cognitive enhancement. We found that the overall willingness to use performance enhancing substances is low. Most respondents considered the use of these substances as morally unacceptable. Situational influences such as peer pressure, policies concerning substance use, relative performance level of peers, but also characteristics of the substance, such as perceptions of substance safety, shape the willingness and acceptability of using a substance to enhance academic performance. Among the findings is evidence of a contagion effect meaning that the willingness was higher when the respondents have more CE drug users in their social network. We also found deterrence effects from strong side effects of using the substance, as well as from policy regulations and sanctions. Regulations might activate social norms against usage and sanctions can be seen as costly to users. Moreover, enhancement substances seem to be most tempting to low performers to catch up with others compared to high performers. By identifying contextual factors and substance characteristics influencing the willingness and acceptability of cognitive enhancers, policy approaches could consider these insights to better manage the use of such substances.
Erscheinungsjahr
2013
Zeitschriftentitel
PLoS ONE
Band
8
Ausgabe
8
Art.-Nr.
e71452
Urheberrecht / Lizenzen
ISSN
1932-6203
eISSN
1932-6203
Finanzierungs-Informationen
Open-Access-Publikationskosten wurden durch die Deutsche Forschungsgemeinschaft und die Universität Bielefeld gefördert.
Page URI
https://pub.uni-bielefeld.de/record/2614390
Zitieren
Sattler S, Forlini C, Racine É, Sauer C. Impact of Contextual Factors and Substance Characteristics on Perspectives toward Cognitive Enhancement. PLoS ONE. 2013;8(8): e71452.
Sattler, S., Forlini, C., Racine, É., & Sauer, C. (2013). Impact of Contextual Factors and Substance Characteristics on Perspectives toward Cognitive Enhancement. PLoS ONE, 8(8), e71452. https://doi.org/10.1371/journal.pone.0071452
Sattler, Sebastian, Forlini, Cynthia, Racine, Éric, and Sauer, Carsten. 2013. “Impact of Contextual Factors and Substance Characteristics on Perspectives toward Cognitive Enhancement”. PLoS ONE 8 (8): e71452.
Sattler, S., Forlini, C., Racine, É., and Sauer, C. (2013). Impact of Contextual Factors and Substance Characteristics on Perspectives toward Cognitive Enhancement. PLoS ONE 8:e71452.
Sattler, S., et al., 2013. Impact of Contextual Factors and Substance Characteristics on Perspectives toward Cognitive Enhancement. PLoS ONE, 8(8): e71452.
S. Sattler, et al., “Impact of Contextual Factors and Substance Characteristics on Perspectives toward Cognitive Enhancement”, PLoS ONE, vol. 8, 2013, : e71452.
Sattler, S., Forlini, C., Racine, É., Sauer, C.: Impact of Contextual Factors and Substance Characteristics on Perspectives toward Cognitive Enhancement. PLoS ONE. 8, : e71452 (2013).
Sattler, Sebastian, Forlini, Cynthia, Racine, Éric, and Sauer, Carsten. “Impact of Contextual Factors and Substance Characteristics on Perspectives toward Cognitive Enhancement”. PLoS ONE 8.8 (2013): e71452.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Access Level
Open Access
Zuletzt Hochgeladen
2019-09-06T09:18:17Z
MD5 Prüfsumme
fe920f45052d53f5181817d2531c261a
Link(s) zu Volltext(en)
Access Level
Closed Access
Daten bereitgestellt von European Bioinformatics Institute (EBI)
15 Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
How perceived substance characteristics affect ethical judgement towards cognitive enhancement.
Mayor E, Daehne M, Bianchi R., PLoS One 14(3), 2019
PMID: 30870469
Mayor E, Daehne M, Bianchi R., PLoS One 14(3), 2019
PMID: 30870469
Bottom Up Ethics - Neuroenhancement in Education and Employment.
Bard I, Gaskell G, Allansdottir A, da Cunha RV, Eduard P, Hampel J, Hildt E, Hofmaier C, Kronberger N, Laursen S, Meijknecht A, Nordal S, Quintanilha A, Revuelta G, Saladié N, Sándor J, Santos JB, Seyringer S, Singh I, Somsen H, Toonders W, Torgersen H, Torre V, Varju M, Zwart H., Neuroethics 11(3), 2018
PMID: 30220937
Bard I, Gaskell G, Allansdottir A, da Cunha RV, Eduard P, Hampel J, Hildt E, Hofmaier C, Kronberger N, Laursen S, Meijknecht A, Nordal S, Quintanilha A, Revuelta G, Saladié N, Sándor J, Santos JB, Seyringer S, Singh I, Somsen H, Toonders W, Torgersen H, Torre V, Varju M, Zwart H., Neuroethics 11(3), 2018
PMID: 30220937
Deciphering moral intuition: How agents, deeds, and consequences influence moral judgment.
Dubljević V, Sattler S, Racine E., PLoS One 13(10), 2018
PMID: 30273370
Dubljević V, Sattler S, Racine E., PLoS One 13(10), 2018
PMID: 30273370
Use and Propensity to Use Substances as Cognitive Enhancers in Italian Medical Students.
Pighi M, Pontoni G, Sinisi A, Ferrari S, Mattei G, Pingani L, Simoni E, Galeazzi GM., Brain Sci 8(11), 2018
PMID: 30423911
Pighi M, Pontoni G, Sinisi A, Ferrari S, Mattei G, Pingani L, Simoni E, Galeazzi GM., Brain Sci 8(11), 2018
PMID: 30423911
Moral Attitudes Toward Pharmacological Cognitive Enhancement (PCE): Differences and Similarities Among Germans With and Without PCE Experience.
Pohl S, Boelsen H, Hildt E., Front Pharmacol 9(), 2018
PMID: 30618746
Pohl S, Boelsen H, Hildt E., Front Pharmacol 9(), 2018
PMID: 30618746
Towards a Moral Ecology of Pharmacological Cognitive Enhancement in British Universities.
Vagwala MK, Bicquelet A, Didziokaite G, Coomber R, Corrigan O, Singh I., Neuroethics 10(3), 2017
PMID: 28890739
Vagwala MK, Bicquelet A, Didziokaite G, Coomber R, Corrigan O, Singh I., Neuroethics 10(3), 2017
PMID: 28890739
Using Caffeine Pills for Performance Enhancement. An Experimental Study on University Students' Willingness and Their Intention to Try Neuroenhancements.
Brand R, Koch H., Front Psychol 7(), 2016
PMID: 26903909
Brand R, Koch H., Front Psychol 7(), 2016
PMID: 26903909
Prescription Psychostimulant Use Among Young Adults: A Narrative Review of Qualitative Studies.
Robitaille C, Collin J., Subst Use Misuse 51(3), 2016
PMID: 26886251
Robitaille C, Collin J., Subst Use Misuse 51(3), 2016
PMID: 26886251
Why is Cognitive Enhancement Deemed Unacceptable? The Role of Fairness, Deservingness, and Hollow Achievements.
Faber NS, Savulescu J, Douglas T., Front Psychol 7(), 2016
PMID: 26925027
Faber NS, Savulescu J, Douglas T., Front Psychol 7(), 2016
PMID: 26925027
Moral and social reasons to acknowledge the use of cognitive enhancers in competitive-selective contexts.
Garasic MD, Lavazza A., BMC Med Ethics 17(), 2016
PMID: 27025299
Garasic MD, Lavazza A., BMC Med Ethics 17(), 2016
PMID: 27025299
Cognitive Enhancement in Healthy Children Will Not Close the Achievement Gap in Education.
Sattler S, Singh I., Am J Bioeth 16(6), 2016
PMID: 27216098
Sattler S, Singh I., Am J Bioeth 16(6), 2016
PMID: 27216098
Associations Between the Big Five Personality Traits and the Non-Medical Use of Prescription Drugs for Cognitive Enhancement.
Sattler S, Schunck R., Front Psychol 6(), 2015
PMID: 26779083
Sattler S, Schunck R., Front Psychol 6(), 2015
PMID: 26779083
The is and ought of the Ethics of Neuroenhancement: Mind the Gap.
Forlini C, Hall W., Front Psychol 6(), 2015
PMID: 26779100
Forlini C, Hall W., Front Psychol 6(), 2015
PMID: 26779100
Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics.
Sattler S, Mehlkop G, Graeff P, Sauer C., Subst Abuse Treat Prev Policy 9(), 2014
PMID: 24484640
Sattler S, Mehlkop G, Graeff P, Sauer C., Subst Abuse Treat Prev Policy 9(), 2014
PMID: 24484640
Attitudes toward pharmacological cognitive enhancement-a review.
Schelle KJ, Faulmüller N, Caviola L, Hewstone M., Front Syst Neurosci 8(), 2014
PMID: 24860438
Schelle KJ, Faulmüller N, Caviola L, Hewstone M., Front Syst Neurosci 8(), 2014
PMID: 24860438
87 References
Daten bereitgestellt von Europe PubMed Central.
Cognitive enhancement: methods, ethics, regulatory challenges.
Bostrom N, Sandberg A., Sci Eng Ethics 15(3), 2009
PMID: 19543814
Bostrom N, Sandberg A., Sci Eng Ethics 15(3), 2009
PMID: 19543814
Psychopharmacological enhancment
AUTHOR UNKNOWN, 2008
AUTHOR UNKNOWN, 2008
Neuroenhancement: status quo and perspectives.
Normann C, Berger M., Eur Arch Psychiatry Clin Neurosci 258 Suppl 5(), 2008
PMID: 18985306
Normann C, Berger M., Eur Arch Psychiatry Clin Neurosci 258 Suppl 5(), 2008
PMID: 18985306
Developing public health approaches to cognitive enhancement: an analysis of current reports
AUTHOR UNKNOWN, 2011
AUTHOR UNKNOWN, 2011
Use of coffee, caffeinated drinks and caffeine tablets for cognitive enhancement in pupils and students in Germany.
Franke AG, Christmann M, Bonertz C, Fellgiebel A, Huss M, Lieb K., Pharmacopsychiatry 44(7), 2011
PMID: 21993866
Franke AG, Christmann M, Bonertz C, Fellgiebel A, Huss M, Lieb K., Pharmacopsychiatry 44(7), 2011
PMID: 21993866
Cognitive Enhancement, Lifestyle Choice or Misuse of Prescription Drugs?
AUTHOR UNKNOWN, 2010
AUTHOR UNKNOWN, 2010
Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences.
Mache S, Eickenhorst P, Vitzthum K, Klapp BF, Groneberg DA., Wien Med Wochenschr 162(11-12), 2012
PMID: 22707077
Mache S, Eickenhorst P, Vitzthum K, Klapp BF, Groneberg DA., Wien Med Wochenschr 162(11-12), 2012
PMID: 22707077
AUTHOR UNKNOWN, 0
Cognitive test anxiety and cognitive enhancement: the influence of students' worries on their use of performance-enhancing drugs.
Sattler S, Wiegel C., Subst Use Misuse 48(3), 2013
PMID: 23302063
Sattler S, Wiegel C., Subst Use Misuse 48(3), 2013
PMID: 23302063
Towards responsible use of cognitive-enhancing drugs by the healthy.
Greely H, Sahakian B, Harris J, Kessler RC, Gazzaniga M, Campbell P, Farah MJ., Nature 456(7223), 2008
PMID: 19060880
Greely H, Sahakian B, Harris J, Kessler RC, Gazzaniga M, Campbell P, Farah MJ., Nature 456(7223), 2008
PMID: 19060880
Effects of modafinil on dopamine and dopamine transporters in the male human brain
AUTHOR UNKNOWN, 2009
AUTHOR UNKNOWN, 2009
What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement.
Franke AG, Lieb K, Hildt E., PLoS ONE 7(6), 2012
PMID: 22768218
Franke AG, Lieb K, Hildt E., PLoS ONE 7(6), 2012
PMID: 22768218
AUTHOR UNKNOWN, 0
Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students.
Dietz P, Striegel H, Franke AG, Lieb K, Simon P, Ulrich R., Pharmacotherapy 33(1), 2013
PMID: 23307544
Dietz P, Striegel H, Franke AG, Lieb K, Simon P, Ulrich R., Pharmacotherapy 33(1), 2013
PMID: 23307544
Use of cognitive enhancement medication among northern Italian university students.
Castaldi S, Gelatti U, Orizio G, Hartung U, Moreno-Londono AM, Nobile M, Schulz PJ., J Addict Med 6(2), 2012
PMID: 22456492
Castaldi S, Gelatti U, Orizio G, Hartung U, Moreno-Londono AM, Nobile M, Schulz PJ., J Addict Med 6(2), 2012
PMID: 22456492
The promise and predicament of cosmetic neurology.
Chatterjee A., J Med Ethics 32(2), 2006
PMID: 16446417
Chatterjee A., J Med Ethics 32(2), 2006
PMID: 16446417
Neurocognitive enhancement: what can we do and what should we do?
AUTHOR UNKNOWN, 2004
AUTHOR UNKNOWN, 2004
The likelihood of cognitive enhancement
AUTHOR UNKNOWN, 2011
AUTHOR UNKNOWN, 2011
Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review.
Repantis D, Laisney O, Heuser I., Pharmacol. Res. 61(6), 2010
PMID: 20193764
Repantis D, Laisney O, Heuser I., Pharmacol. Res. 61(6), 2010
PMID: 20193764
Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review.
Repantis D, Schlattmann P, Laisney O, Heuser I., Pharmacol. Res. 62(3), 2010
PMID: 20416377
Repantis D, Schlattmann P, Laisney O, Heuser I., Pharmacol. Res. 62(3), 2010
PMID: 20416377
Antidepressants for neuroenhancement in healthy individuals: a systematic review
AUTHOR UNKNOWN, 2008
AUTHOR UNKNOWN, 2008
Methylphenidate facilitates learning-induced amygdala plasticity.
Tye KM, Tye LD, Cone JJ, Hekkelman EF, Janak PH, Bonci A., Nat. Neurosci. 13(4), 2010
PMID: 20208527
Tye KM, Tye LD, Cone JJ, Hekkelman EF, Janak PH, Bonci A., Nat. Neurosci. 13(4), 2010
PMID: 20208527
Cognitive enhancement by drugs in health and disease.
Husain M, Mehta MA., Trends Cogn. Sci. (Regul. Ed.) 15(1), 2010
PMID: 21146447
Husain M, Mehta MA., Trends Cogn. Sci. (Regul. Ed.) 15(1), 2010
PMID: 21146447
Weak evidence for large claims contribute to the phantom debate
AUTHOR UNKNOWN, 2010
AUTHOR UNKNOWN, 2010
The use of methylphenidate among students: the future of enhancement?
Outram SM., J Med Ethics 36(4), 2010
PMID: 20338928
Outram SM., J Med Ethics 36(4), 2010
PMID: 20338928
Ethical considerations in the framing of the cognitive enhancement debate
AUTHOR UNKNOWN, 2012
AUTHOR UNKNOWN, 2012
Expectations regarding cognitive enhancement create substantial challenges.
Racine E, Forlini C., J Med Ethics 35(8), 2009
PMID: 19644002
Racine E, Forlini C., J Med Ethics 35(8), 2009
PMID: 19644002
On the argument that enhancement is "cheating".
Schermer M., J Med Ethics 34(2), 2008
PMID: 18234944
Schermer M., J Med Ethics 34(2), 2008
PMID: 18234944
The nonmedical use of prescription ADHD medications: results from a national Internet panel.
Novak SP, Kroutil LA, Williams RL, Van Brunt DL., Subst Abuse Treat Prev Policy 2(), 2007
PMID: 17974020
Novak SP, Kroutil LA, Williams RL, Van Brunt DL., Subst Abuse Treat Prev Policy 2(), 2007
PMID: 17974020
Perceived harmfulness predicts nonmedical use of prescription drugs among college students: interactions with sensation-seeking.
Arria AM, Caldeira KM, Vincent KB, O'Grady KE, Wish ED., Prev Sci 9(3), 2008
PMID: 18633709
Arria AM, Caldeira KM, Vincent KB, O'Grady KE, Wish ED., Prev Sci 9(3), 2008
PMID: 18633709
Nonmedical prescription stimulant use among a sample of college students: relationship with psychological variables.
Weyandt LL, Janusis G, Wilson KG, Verdi G, Paquin G, Lopes J, Varejao M, Dussault C., J Atten Disord 13(3), 2009
PMID: 19767596
Weyandt LL, Janusis G, Wilson KG, Verdi G, Paquin G, Lopes J, Varejao M, Dussault C., J Atten Disord 13(3), 2009
PMID: 19767596
Risk and protective factors for nonmedical use of prescription stimulants and methamphetamine among adolescents.
Herman-Stahl MA, Krebs CP, Kroutil LA, Heller DC., J Adolesc Health 39(3), 2006
PMID: 16919799
Herman-Stahl MA, Krebs CP, Kroutil LA, Heller DC., J Adolesc Health 39(3), 2006
PMID: 16919799
Attitudes toward cognitive enhancement in users and nonusers of stimulants for cognitive enhancement: a pilot study
AUTHOR UNKNOWN, 2012
AUTHOR UNKNOWN, 2012
Perceived risk and use as predictors of substance use among college students
AUTHOR UNKNOWN, 1995
AUTHOR UNKNOWN, 1995
Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey.
McCabe SE, Knight JR, Teter CJ, Wechsler H., Addiction 100(1), 2005
PMID: 15598197
McCabe SE, Knight JR, Teter CJ, Wechsler H., Addiction 100(1), 2005
PMID: 15598197
Motives and perceived consequences of nonmedical ADHD medication use by college students: are students treating themselves for attention problems?
Rabiner DL, Anastopoulos AD, Costello EJ, Hoyle RH, McCabe SE, Swartzwelder HS., J Atten Disord 13(3), 2008
PMID: 18664714
Rabiner DL, Anastopoulos AD, Costello EJ, Hoyle RH, McCabe SE, Swartzwelder HS., J Atten Disord 13(3), 2008
PMID: 18664714
AUTHOR UNKNOWN, 0
Multiple surveys of students and survey fatigue
AUTHOR UNKNOWN, 2004
AUTHOR UNKNOWN, 2004
Influence of preliminary contact on mail returns
AUTHOR UNKNOWN, 1966
AUTHOR UNKNOWN, 1966
Incentives in web surveys: methodological issues and a review
AUTHOR UNKNOWN, 2006
AUTHOR UNKNOWN, 2006
Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount.
Banjo OC, Nadler R, Reiner PB., PLoS ONE 5(12), 2010
PMID: 21179461
Banjo OC, Nadler R, Reiner PB., PLoS ONE 5(12), 2010
PMID: 21179461
Enhancing concentration, mood and memory in healthy individuals: an empirical study of attitudes among general practitioners and the general population.
Bergstrom LS, Lynoe N., Scand J Public Health 36(5), 2008
PMID: 18635734
Bergstrom LS, Lynoe N., Scand J Public Health 36(5), 2008
PMID: 18635734
"Doctor, would you prescribe a pill to help me … ?" a national survey of physicians on using medicine for human enhancement.
Hotze TD, Shah K, Anderson EE, Wynia MK., Am J Bioeth 11(1), 2011
PMID: 21240795
Hotze TD, Shah K, Anderson EE, Wynia MK., Am J Bioeth 11(1), 2011
PMID: 21240795
Factorial survey methods for studying beliefs and judgments
AUTHOR UNKNOWN, 2006
AUTHOR UNKNOWN, 2006
Judgments of the fairness of using performance enhancing drugs.
Sabini J, Monterosso J., Ethics Behav 15(1), 2005
PMID: 16127858
Sabini J, Monterosso J., Ethics Behav 15(1), 2005
PMID: 16127858
25 years of factorial surveys in sociology: a review
AUTHOR UNKNOWN, 2009
AUTHOR UNKNOWN, 2009
Who should get what? Fairness judgments of the distribution of earnings
AUTHOR UNKNOWN, 1978
AUTHOR UNKNOWN, 1978
Der faktorielle Survey und die Messung von Normen
AUTHOR UNKNOWN, 2001
AUTHOR UNKNOWN, 2001
The vagaries of the vignette world. A comment on Alves and Rossi
AUTHOR UNKNOWN, 1980
AUTHOR UNKNOWN, 1980
Rejoinder to Faia
AUTHOR UNKNOWN, 1980
AUTHOR UNKNOWN, 1980
The Vignette Technique in Survey Research
AUTHOR UNKNOWN, 1987
AUTHOR UNKNOWN, 1987
The federal ban on ephedrine dietary supplements. an important event for pain practitioners and patients
AUTHOR UNKNOWN, 2004
AUTHOR UNKNOWN, 2004
Over-the-counter stimulants: abuse and addiction.
Tinsley JA, Watkins DD., Mayo Clin. Proc. 73(10), 1998
PMID: 9787749
Tinsley JA, Watkins DD., Mayo Clin. Proc. 73(10), 1998
PMID: 9787749
The use of vignettes in survey research
AUTHOR UNKNOWN, 1978
AUTHOR UNKNOWN, 1978
An examination of the effects of social desirability bias on business ethics: research results
AUTHOR UNKNOWN, 2002
AUTHOR UNKNOWN, 2002
Designing vignette studies in marketing
AUTHOR UNKNOWN, 2002
AUTHOR UNKNOWN, 2002
AUTHOR UNKNOWN, 0
AUTHOR UNKNOWN, 0
Deflating the neuroenhancement bubble
AUTHOR UNKNOWN, 2011
AUTHOR UNKNOWN, 2011
Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee.
Larriviere D, Williams MA, Rizzo M, Bonnie RJ; AAN Ethics, Law and Humanities Committee, Williams MA, Larriviere D, Gordon J, Bernat JL, Evans P, Haberfeld E, Jacobson PL, King DW, McGuire D, Reimschisel T, Rizzo M, Snyder RD, Sagsveen MG, Hutchins JC, Kasmirski KM., Neurology 73(17), 2009
PMID: 19776378
Larriviere D, Williams MA, Rizzo M, Bonnie RJ; AAN Ethics, Law and Humanities Committee, Williams MA, Larriviere D, Gordon J, Bernat JL, Evans P, Haberfeld E, Jacobson PL, King DW, McGuire D, Reimschisel T, Rizzo M, Snyder RD, Sagsveen MG, Hutchins JC, Kasmirski KM., Neurology 73(17), 2009
PMID: 19776378
AUTHOR UNKNOWN, 0
Smart drugs "as common as coffee": media hype about neuroenhancement.
Partridge BJ, Bell SK, Lucke JC, Yeates S, Hall WD., PLoS ONE 6(11), 2011
PMID: 22140584
Partridge BJ, Bell SK, Lucke JC, Yeates S, Hall WD., PLoS ONE 6(11), 2011
PMID: 22140584
Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement.
Forlini C, Racine E., BMC Med Ethics 10(), 2009
PMID: 19580661
Forlini C, Racine E., BMC Med Ethics 10(), 2009
PMID: 19580661
AUTHOR UNKNOWN, 0
Time to address stimulant abuse on our campuses.
Rosenfield D, Hebert PC, Stanbrook MB, Flegel K, MacDonald NE., CMAJ 183(12), 2011
PMID: 21896701
Rosenfield D, Hebert PC, Stanbrook MB, Flegel K, MacDonald NE., CMAJ 183(12), 2011
PMID: 21896701
Autonomy and coercion in academic “cognitive enhancement” using methylphenidate: perspectives of a pragmatic study of key stakeholders
AUTHOR UNKNOWN, 2009
AUTHOR UNKNOWN, 2009
Commercializing cognitive neurotechnology--the ethical terrain.
Eaton ML, Illes J., Nat. Biotechnol. 25(4), 2007
PMID: 17420741
Eaton ML, Illes J., Nat. Biotechnol. 25(4), 2007
PMID: 17420741
Risk and rationality in adolescent decision making: implications for theory, practice, and public policy
AUTHOR UNKNOWN, 2006
AUTHOR UNKNOWN, 2006
To use or not to use: Expanding the view on non-addictive psychoactive drug consumption and its implications.
Muller CP, Schumann G., Behav Brain Sci 34(6), 2011
PMID: 22379623
Muller CP, Schumann G., Behav Brain Sci 34(6), 2011
PMID: 22379623
AUTHOR UNKNOWN, 0
Using social networks to understand and prevent substance use: a transdisciplinary perspective.
Valente TW, Gallaher P, Mouttapa M., Subst Use Misuse 39(10-12), 2004
PMID: 15587948
Valente TW, Gallaher P, Mouttapa M., Subst Use Misuse 39(10-12), 2004
PMID: 15587948
AUTHOR UNKNOWN, 0
Predicting dishonest actions using the theory of planned behavior
AUTHOR UNKNOWN, 1991
AUTHOR UNKNOWN, 1991
The interplay of moral norms and instrumental incentives in crime causation
AUTHOR UNKNOWN, 2010
AUTHOR UNKNOWN, 2010
Expected utility, self-control, morality, and criminal probability
AUTHOR UNKNOWN, 2010
AUTHOR UNKNOWN, 2010
Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.
Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S., J Am Acad Child Adolesc Psychiatry 47(1), 2008
PMID: 18174822
Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S., J Am Acad Child Adolesc Psychiatry 47(1), 2008
PMID: 18174822
University students' perceptions of the learning environment and academic outcomes: implications for theory and practice
AUTHOR UNKNOWN, 2002
AUTHOR UNKNOWN, 2002
Approaches to teaching design subjects: a quantitative analysis
AUTHOR UNKNOWN, 2002
AUTHOR UNKNOWN, 2002
The Impact of Anonymity on Responses to Sensitive Questions
AUTHOR UNKNOWN, 2000
AUTHOR UNKNOWN, 2000
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 23940757
PubMed | Europe PMC
Suchen in